Provided by Tiger Trade Technology Pte. Ltd.

Repligen

170.02
-10.9600-6.06%
Post-market: 170.020.00000.00%16:15 EDT
Volume:1.41M
Turnover:239.87M
Market Cap:9.57B
PE:232.90
High:182.57
Open:180.70
Low:167.42
Close:180.98
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.80
T/O Rate:2.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.53
PE(LYR):197.70

Loading ...

Analysts Offer Insights on Healthcare Companies: Community Health (CYH), AnaptysBio (ANAB) and Repligen (RGEN)

TIPRANKS
·
Jul 23

France's Sartorius Stedim Biotech H1 Revenue Rises on Recurring Consumables

Reuters
·
Jul 23

Biolife Solutions Co May be Required to Pay Repligen Termination Fee of $59 Million, if Deal Terminates Under Certain Circumstances- SEC Filing

Reuters
·
Jul 23

Medpace Q2 Revenue Beats Estimates on Backlog Conversion

Reuters
·
Jul 23

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live
·
Jul 23

Hold Rating Maintained as Repligen Acquisition Caps BioLife Upside; Price Target Cut to $31 from $33

TIPRANKS
·
Jul 22

Repligen to Acquire BioLife, Expanding Cell Therapy Reach

TIPRANKS
·
Jul 22

Repligen Corp: if Deal Terminated Under Some Circumstances, Biolife May be Required to Pay Repligen a Termination Fee of $59 Mln

THOMSON REUTERS
·
Jul 22

Shares of Biolife up 3.1% Premarket After $1.5 Billion Repligen Buyout

THOMSON REUTERS
·
Jul 22

Repligen Down 2.7%

THOMSON REUTERS
·
Jul 22

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Repligen to Buy Biolife Solutions for About USD 1.5 Billion, Offers USD 31 a Share

Reuters
·
Jul 22

Biolife Solutions - Repligen to Buy Biolife for $1.50 Bln Enterprise Value, 64% Stock, 36% Cash

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Repligen Preliminary Q2 Reported Revenue Growth 12%, Organic Revenue Growth 13%

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Stockholders to Receive $11.25 Cash and 0.1442 Repligen Shares Per Biolife Share

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Preliminary Q2 Revenue Growth 21% Year-over-year

THOMSON REUTERS
·
Jul 22

Repligen to Acquire Biolife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Repligen Expects at Least $20 Mln Synergies in Year One, $30 Mln in Year Two

THOMSON REUTERS
·
Jul 22

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

GlobeNewswire
·
Jul 22

Earnings Preview: Repligen revenue is expected to increase by 15%, and institutional views are constructive

Earnings Agent
·
Jul 21